Developer site: The content shown here is test data.

Health Dictionary AI Health Chat Find an Online Doctor
A serene Zen garden with raked sand and smooth stones, symbolising clarity and calm

Health Dictionary

Back to skin conditions

Lupus nephritis natural history, complications and prognosis

Introduction

Overview

Overview

Common complications of Lupus nephritis include microscopic hematuria, nephrotic syndrome, celluar casts, elevated creatnine and destruction of more than 50% of glomeruli.

Natural History, Complications, and Prognosis

Natural History, Complications, and Prognosis

Natural History

Lupus nephritis may damage different parts of the kidney. Class I has normal histology and does not show any evidence of disease and class V shows an extensive disease.

Complications

Possible complications include:[3]

Prognosis

  • Prognosis is generally poor for class IV, and the 50% survival is 15/+- 2.5 years.[6][7]
References

References

  1. ↑ Cervera R, Khamashta MA, Font J, Sebastiani GD, Gil A, Lavilla P, Doménech I, Aydintug AO, Jedryka-Góral A, de Ramón E (March 1993). “Systemic lupus erythematosus: clinical and immunologic patterns of disease expression in a cohort of 1,000 patients. The European Working Party on Systemic Lupus Erythematosus”. Medicine (Baltimore). 72 (2): 113–24. PMID 8479324.
  2. ↑ Seligman VA, Lum RF, Olson JL, Li H, Criswell LA (June 2002). “Demographic differences in the development of lupus nephritis: a retrospective analysis”. Am. J. Med. 112 (9): 726–9. PMID 12079714.
  3. ↑ 3.0 3.1 3.2 Cervera R, Khamashta MA, Font J, Sebastiani GD, Gil A, Lavilla P, Mejía JC, Aydintug AO, Chwalinska-Sadowska H, de Ramón E, Fernández-Nebro A, Galeazzi M, Valen M, Mathieu A, Houssiau F, Caro N, Alba P, Ramos-Casals M, Ingelmo M, Hughes GR (September 2003). “Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients”. Medicine (Baltimore). 82 (5): 299–308. doi:10.1097/01.md.0000091181.93122.55. PMID 14530779.
  4. ↑ 4.0 4.1 4.2 4.3 4.4 Almaani S, Meara A, Rovin BH (May 2017). “Update on Lupus Nephritis”. Clin J Am Soc Nephrol. 12 (5): 825–835. doi:10.2215/CJN.05780616. PMC 5477208. PMID 27821390.
  5. ↑ 5.0 5.1 5.2 5.3 5.4 5.5 Alarcón GS (2011). “Multiethnic lupus cohorts: what have they taught us?”. Reumatol Clin. 7 (1): 3–6. doi:10.1016/j.reuma.2010.11.001. PMID 21794772.
  6. ↑ Kashgarian M (March 1994). “Lupus nephritis: lessons from the path lab”. Kidney Int. 45 (3): 928–38. PMID 8196299.
  7. ↑ Yokoyama H, Wada T, Hara A, Yamahana J, Nakaya I, Kobayashi M, Kitagawa K, Kokubo S, Iwata Y, Yoshimoto K, Shimizu K, Sakai N, Furuichi K (December 2004). “The outcome and a new ISN/RPS 2003 classification of lupus nephritis in Japanese”. Kidney Int. 66 (6): 2382–8. doi:10.1111/j.1523-1755.2004.66027.x. PMID 15569330.

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Omer Kamal, M.D.[2] Cafer Zorkun, M.D., Ph.D. [2], Raviteja Guddeti, M.B.B.S. [3]